Get the Stockscreener App
0.1101
28.55%
-0.044
After Hours:
.11
-0.0001
-0.09%
Geovax Labs Inc stock is traded at $0.1101, with a volume of 24,286.
It is down -28.55% in the last 24 hours and down -45.09% over the past month.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
See More
Previous Close:
$0.1541
Open:
$0.1373
24h Volume:
24,286
Relative Volume:
0.66
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-49.95%
1M Performance:
-45.09%
6M Performance:
+313.75%
1Y Performance:
+0.00%
1-Day Range:
$0.105
$0.1373
1-Week Range:
$0.105
$0.253
52-Week Range:
$0.02
$34.93
Geovax Labs Inc Stock (GOVXW) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678 384 7220
Address
1900 Lake Park Drive, Suite 380, Smyrna
Geovax Labs Inc Stock (GOVXW) Latest News
Geovax Labs Inc [NASDAQ: GOVX] Sees Decrease in Stock Value - Knox Daily
GeoVax Labs inks sales agreement, may offer stock By Investing.com - Investing.com Canada
GeoVax Labs inks sales agreement, may offer stock - Investing.com India
GeoVax Labs inks sales agreement, may offer stock By Investing.com - Investing.com Australia
GeoVax Labs inks sales agreement, may offer stock - Investing.com
Form 424B5 GeoVax Labs, Inc. - StreetInsider.com
GeoVax Labs, Inc. (NASDAQ:GOVXW) Short Interest Update - Defense World
Nothing is Better Than Geovax Labs Inc (GOVX) stock at the moment - SETE News
Monitoring Geovax Labs Inc (GOVX) after recent insider movements - Knox Daily
Globus Medical, Inc. (NYSE:GMED) Shares Purchased by Envestnet Asset Management Inc. - MarketBeat
GEELY AUTO Partners with Tasco to Set Up Auto Assembly Plant in Vietnam w/ Total Investment Amt ~US$168M - AASTOCKS.com
GameStop up after raising $400 mln from equity offering - XM
Gevo Inc (GEVO) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
Gevo Inc (GEVO) stock: A year of ups and downs - US Post News
GOVX’s Stock Market Adventure: -45.52% YTD Growth Amidst Volatility - The InvestChronicle
Trading Day Review: Geovax Labs Inc (GOVX) Gains Momentum, Closing at 2.95 - The Dwinnex
A company insider recently bought 8,000 shares of Geovax Labs Inc [GOVX]. Should You Buy? - Knox Daily
GeoVax postpones special meeting due to low turnout - Investing.com India
Mpox: Gavi secures 500,000 doses of vaccines for Africa - The Nation Newspaper
Short Interest in Gevo, Inc. (NASDAQ:GEVO) Increases By 8.1% - Defense World
Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine - Winnipeg Free Press
Gevo (NASDAQ:GEVO) shareholders are up 132% this past week, but still in the red over the last three years - Simply Wall St
A new trading data show Geovax Labs Inc (GOVX) is showing positive returns. - SETE News
Gevo surges to highest in 18 months after U.S. patent grant, ethanol plant deal - MSN
Understanding the Risks of Investing in Geovax Labs Inc (GOVX) - Knox Daily
GeoVax postpones special meeting due to low turnout - Investing.com
Geovax Labs Inc (GOVX) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Examining Geovax Labs Inc (GOVX) more closely is necessary - US Post News
Geovax Labs Inc [GOVX] stock for 15,600 USD was bought by DODD DAVID A - Knox Daily
Financial Health Report: Geovax Labs Inc (GOVX)’s Ratios Tell a Tale - The Dwinnex
Get in on Geovax Labs Inc’s (GOVX) buy-in window today! - SETE News
Geovax Labs Inc [GOVX] Stock bought by Insider DODD DAVID A for $15600.0 - Knox Daily
Geovax Labs Inc (GOVX) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
What was Geovax Labs Inc (GOVX)’s performance in the last session? - US Post News
Balance Sheet Breakdown: Geovax Labs Inc (GOVX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Geovax Labs Inc [GOVX] President, CEO makes an insider purchase of 8,000 shares worth 15600.0. - Knox Daily
Geovax Labs Inc (GOVX) can make a big difference with a little luck - SETE News
Geovax Labs Inc (GOVX) is a good investment, but the stock may be undervalued - US Post News
GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move - Insider Monkey
GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move - Yahoo Finance
GeoVax to Participate in Upcoming Investor Conferences in September - GlobeNewswire
GeoVax to Participate in Upcoming Investor Conferences in September - StockTitan
Geovax Labs Inc (GOVX) Stock: From Low to High in 52 Weeks - The InvestChronicle
Ratio Review: Analyzing Geovax Labs Inc (GOVX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
GeoVax Labs to Present at Two Investor Conferences in September - Vancity Buzz
10 Hot Penny Stocks On the Move - Insider Monkey
GeoVax Labs to raise $5M via private placement - MSN
EF Hutton Initiates Coverage of GeoVax Labs (GOVX) with Buy Recommendation - MSN
GeoVax Labs Accelerates Capital Raise with Multiple Offerings - TipRanks
GOVX’s valuation metrics: A comprehensive analysis - US Post News
GeoVax Labs, Inc. (NASDAQ:GOVXW) Short Interest Up 500.0% in August - Defense World
Geovax Labs Inc Stock (GOVXW) Financials Data
There is no financial data for Geovax Labs Inc (GOVXW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Cap:
|
Volume (24h):